Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers

Journal of Analytical Toxicology

Volumn 36, Issue 7, 2012, Pages 507-514

  Valtier, Sandra ^a   Bebarta, Vikhyat S ^a  

^a Lackland AFB ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; HYDROCODONE; HYDROMORPHONE; NORHYDROCODONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84870703709     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks058     Document Type: Article

References (28)

1. Drug Abuse Warning Network, 2008: National Estimates of Drug-Related Emergency Department Visits (2011) HHS Publication No. SMA 11-4618. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, Rockville, MD.
2. Results from the 2008 National Survey on Drug Use and Health: National Findings, NSDUH Series H-36, HHS Publication No. SMA 09-4434 (2009) Substance Abuse and Mental Health Services Administration, Rockville, MD.
3. National Survey of American Attitudes on Substance Abuse XV: Teens and Parents (2010) National Center on Addiction and Substance Abuse at Columbia University, New York, NY.
4. Hughes, A.A., Bogdan, G.M., Dart, R.C. (2007) Active surveillance of abused and misused prescription opioids using poison center data: A pilot study and descriptive comparison. Clinical Toxicology (Philadelphia), 45, 144-151.
5. Baker, D.D., Jenkins, A.J. (2008) A comparison of methadone, oxycodone, and hydrocodone related deaths in Northeast Ohio. Journal of Analytical Toxicology, 32, 165-171.
6. Otton, S.V., Schadel, M., Cheung, S.W., Kaplan, H.L., Busto, U.E., Sellers, E.M. (1993) CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Clinical Pharmacology and Therapeutics, 54, 463-472.
7. Cone, E.J., Darwin, W.D., Gorodetzky, C.W., Tan, T. (1978) Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Drug Metabolism and Disposition, 6, 488-493.
8. Cone, E.J., Darwin, W.D. (1978) Simultaneous determination of hydromorphone, hydrocodone and their 6alpha- and 6betahydroxy metabolites in urine using selected ion recording with methane chemical ionization. Biomedical Mass Spectrometry, 5, 291.
9. Parfitt, K. ed. (1999) Martindale The complete drug reference. 32nd edition, Pharmaceutical Press, Taunton, MA, pp. 2315.
10. Lalovic, B., Kharasch, E., Hoffer, C., Risler, L., Liu-Chen, L.Y., Shen, D.D. (2006) Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites. Clinical Pharmacology & Therapeutics, 79, 461-479.
11. Hutchinson, M.R., Menelaou, A., Foster, D.J., Coller, J.K., Somogyi, A.A. (2004) CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. British Journal of Clinical Pharmacology, 57, 287-297.
12. Eichelbaum, M., Gross, A.S. (1990) The genetic polymorphism of debrisoquine/sparteine metabolism-Clinical aspects. Pharmacology and Therapeutics, 46, 377-394.
13. Kaplan, H.L., Busto, U.E., Baylon, G.J., Cheung, S.W., Otton, S.V., Somer, G. (1997) Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. Journal of Pharmacology and Experimental Therapeutics, 281, 103-108.
14. Heltsley, R., Zichterman, A., Black, D.L., Cawthon, B., Robert, T., Moser, F. et al. (2010) Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites. Journal of Analytical Toxicology, 34, 32-38.
15. Cone, E.J., Zichterman, A., Heltsley, R., Black, D.L., Cawthon, B., Robert, T. et al. (2010) Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives. Forensic Science International, 198, 58-61.
16. Dahn, T., Gunn, J., Kriger, S., Terrell, A.R. (2010) Quantitation of morphine, codeine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine, blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detection. Methods in Molecular Biology, 603, 411-22.
17. Coles, R., Kushnir, M.M., Nelson, G.J., McMillin, G.A., Urry, F.M. (2007) Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS. Journal of Analytical Toxicology, 31, 1-14.
18. Goldberger, B.A., Chronister, C.W., Merves, M.L. (2010) Quantitation of opioids in blood and urine using gas chromatography-mass spectrometry (GC-MS). Methods in Molecular Biology, 603, 399-410.
19. Chen, Y.L., Hanson, G.D., Jiang, X., Naidong, W. (2002) Simultaneous determination of hydrocodone and hydromorphone in human plasma by liquid chromatography with tandem mass spectrometric detection. Journal of Chromatography B, 769, 55-64.
20. Zhang, R., Wang, B., Wei, C., Yuan, G., Guo, R. (2009) Determination and pharmacokinetic study of hydrocodone in human plasma by liquid chromatography coupled with tandem mass spectrometry. Artificial Cells, Blood Substitutes, Immobilization and Biotechnology, 37, 203-207.
21. Meatherall, R. (1999) GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine. Journal of Analytical Toxicology, 23, 177-186.
22. Meatherall, R. (2005) GC-MS quantitation of codeine, morphine, 6- acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood. Journal of Analytical Toxicology, 29, 301-308.
23. Edinboro, L.E., Backer, R.C., Poklis, A. (2005) Direct analysis of opiates in urine by liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 29, 704-710.
24. Cone, E.J., Caplan, Y.H., Black, D.L., Robert, T., Moser, F. (2008) Urine drug testing of chronic pain patients: Licit and illicit drug patterns. Journal of Analytical Toxicology, 32, 530-543.
25. Smith, M.L., Hughes, R.O., Levine, B., Dickerson, S., Darwin, W.D., Cone, E.J. (1995) Forensic drug testing for opiates VI. Urine testing for hydromorphone, hydrocodone, oxymorphone and oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry. Journal of Analytical Toxicology, 19, 18-26.
26. Cone, E.J., Caplan, Y.H., Moser, F., Robert, T., Shelby, M.K., Black, D.L. (2009) Normalization of urinary drug concentrations with specific gravity and creatinine. Journal of Analytical Toxicology, 33, 1-7.
27. Lafolie, P., Beck, O., Blennow, G., Boreus, L., Borg, S., Elwin, C.E. (1991) Importance of creatinine analyses of urine when screening for abused drugs. Clinical Chemistry, 37, 1927-1931.
28. Department of Health and Human Services Substance Abuse and Mental Health Services Administration. (2004) Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs; Notices. Federal Register, 69, 19644-19673.